Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CELLECTAR BIOSCIENCES, INC.”

7 pharma patents match "CELLECTAR BIOSCIENCES, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "CELLECTAR BIOSCIENCES, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “CELLECTAR BIOSCIENCES, INC.” · 30,257 patents in full index Clear search

  1. US 11439709

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted
  2. US 9925269

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  3. US 9616140

    Fluorescent phospholipid ether compounds, compositions, and methods of use

    CELLECTAR BIOSCIENCES, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted
  4. US 9579406

    Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof

    CELLECTAR BIOSCIENCES, INC. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  5. US 9550002

    Phospholipid analogs as diapeutic agents and methods thereof

    CELLECTAR BIOSCIENCES, INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  6. US 9480754

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  7. US 9345718

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted May 24, 2016 · Expires May 19, 2036

    granted